Semen analysis

About: Semen analysis is a research topic. Over the lifetime, 4909 publications have been published within this topic receiving 143225 citations.

Novel mutations in testis-specific ubiquitin protease 26 gene may cause male infertility and hypogonadism

Abstract: Patients (n = 188) with non-obstructive azoospermia (NOA), and 17 fertile controls were screened for sequence changes in the ubiquitin specific protease (USP) 26 gene. Semen analysis, hormonal evaluation, and testicular biopsies were performed. DNA was extracted from whole blood. Denaturing high-performance liquid chromatography was used to screen for single nucleotide polymorphisms. Amino acid sequences were determined in samples with mutations. Twenty out of 188 (10.6%) infertile men had amino acid changes in USP26. No changes were found in fertile controls. 1090C→T substitution and (363insACA; 494T→C; 1423C→T) change were found in 3.3 and 1.9% of patients respectively. Serum testosterone concentrations and testicular volume were lower in the mutation positive group compared with the non-mutation group (272 versus 366 ng/dl; P = 0.01) (volume: 7.88 versus 10 ml, P = 0.03). Six out of 28 (21%) patients with Sertoli cell-only syndrome, and two out of 18 (11%) patients with maturation arrest had mutations in the USP26 gene. There were no live deliveries in couples with the USP26+ mutation, and three live deliveries in the group without mutations. The USP26 gene may be of importance in male reproduction. Mutations in this gene may be associated with male infertility, and may negatively affect testicular function.

Structural damage to nuclear DNA in mammalian spermatozoa: its evaluation techniques and relationship with male infertility.

Abstract: Diagnosis of the fertilizing ability of a semen sample is important for consistently high reproductive efficiency. Disturbances in the organization of the genomic material in sperm nuclei can have a serious impact on the growth of the offspring, therefore a stable nuclear matrix is crucial for participation in embryonic development. Routine semen analysis investigates parameters such as sperm motility and morphology, but does not examine the nuclear DNA integrity of spermatozoa. It has been suggested that altered nuclear chromatin structure or damaged DNA in spermatozoa is implicated as a possible cause of increased infertility in males. Therefore, it is crucial to develop and use accurate and diagnostic tests, which may provide better prognostic capabilities than the standard sperm assessments. This article reviews and discusses some of the current techniques employed for evaluating chromatin structure or DNA damage in spermatozoa. These different techniques include the comet assay, sperm chromatin structure assay (SCSA), acridine orange test (AOT), tritium-labelled 3H-actinomycin D (3H-AMD) incorporation assay, terminal TdT-mediated dUTP-nick-end labelling (TUNEL) assay, in-situ nick translation (ISNT) assay, DNA breakage detection-fluorescence in-situ hybridizations (DBD-FISH) assay and sperm chromatin dispersion (SCD) test. The aforementioned assays, which are considered independent measure of sperm quality, may help to detect subtle defects in the chromatin structure or DNA integrity, and thereby assist in semen quality assessment. The relationship between DNA damage and male infertility is also addressed.

In vivo scavenging effect of ethylcysteine on reactive oxygen species in human semen

Abstract: Purpose The production of reactive oxygen species (ROS) is a normal physiological event in various organs including the testis. Overproduction of ROS, however, can be detrimental to sperm, being associated with male infertility. In vivo experiments using vitamin E (Vit. E), one of the major membrane protectants against ROS and lipid peroxidation, have shown its significant potential in treating ROS-associated male infertility. There has been no study that the scavenging drugs reduce the level of ROS in human semen. Previously we reported the in vitro scavenging effectiveness of ethylcysteine (EC) against ROS in human semen. The present study was performed in order to determine the effectiveness of the in vivo administration of EC as treatment for ROS-associated male infertility. Patients and methods Ten cases of male infertility, with the exceptions of azoospermia and pyospermia, were chosen. Patients were divided randomly into two groups. Each group received either 600 mg/day of EC (Group A) or Vit. E 600 mg/day (Group B) for 3 months. Then, after a 1-month wash-out period, the patients were switched to another treatment. Conventional semen analysis, computerized motility assessment, measurement of ROS generation and sperm function assessment by triple stain were performed before and after administration of EC and Vit. E. The levels of EC and Vit. E were also assessed in patients' blood serum and seminal plasma before and after administration of EC and Vit. E. Results Sperm density and sperm motility did not improve but sperm function had a significant tendency toward improvement after administration of EC and Vit. E. ROS levels significantly decreased only after administration of EC After administration of EC and Vit. E, their levels significantly increased in patients' blood serum but were unchanged in patients' seminal plasma. Conclusion Since our study showed that oral administration of EC produced results similar to those of Vit. E, we conclude that EC is an effective treatment agent for ROS-associated male infertility.

Semen cryopreservation and artificial insemination for Hodgkin's disease.

Abstract: Seventy-nine men with Hodgkin's disease were treated with chemotherapy protocols at Memorial Sloan-Kettering Cancer Center and had pretreatment semen analysis performed at the area semen bank. The patients were evaluated to determine: the quality of pretreatment semen, the effect of treatment on spermatogenesis, and the success rate of artificial insemination after semen cryopreservation. Pretreatment sperm concentration, fresh motility, fresh progression, postthaw motility and postthaw progression were all significantly decreased in men with Hodgkin's disease compared with normal controls. Posttreatment semen analysis in 44 men showed azoospermia in 80%, sperm concentration, less than or equal to 10 X 10(6)/mL in 11%, and sperm concentration greater than 10 X 10(6)/mL in 9%. Eleven couples attempted artificial insemination using cryopreserved semen, thus far resulting in three pregnancies. Semen cryopreservation and artificial insemination offer a partial solution to posttreatment azoospermia in this pop...